Open Journal of Pediatrics
Vol.3 No.2(2013), Paper ID 33217, 14
pages
DOI:10.4236/ojped.2013.32027
Risk and benefit from clinical trials in minors: Making the case for transparent and consistent publications
Andreas Dirk Henschel, Lillian Geza Rothenberger, Dominik Schrey, Joachim Gerß, Georg Hempel, Joachim Boos
Department of Pharmaceutical and Medical Chemistry—Clinical Pharmacy, University of Münster, Münster, Germany
Institute of Ethics and History in Medicine, Center for Medicine, Society and Prevention, University of Tuebingen, Germany
The Royal Marsden Hospital, Department of Paediatric Oncology, Surrey, UK
Institute for Biostatistics and Clinical Research, University of Muenster, Germany
Department of Pharmaceutical and Medical Chemistry—Clinical Pharmacy, University of Münster, Münster, Germany
Department of Pediatric Hematology and Oncology, University Children’s Hospital, Muenster Albert-Schweitzer-Campus, Muenster, Germany
Copyright © 2013 Andreas Dirk Henschel, Lillian Geza Rothenberger, Dominik Schrey, Joachim Gerß, Georg Hempel, Joachim Boos et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Henschel, A. , Rothenberger, L. , Schrey, D. , Gerß, J. , Hempel, G. and Boos, J. (2013) Risk and benefit from clinical trials in minors: Making the case for transparent and consistent publications.
Open Journal of Pediatrics,
3, 151-164. doi:
10.4236/ojped.2013.32027.